Instead of giving handouts to Big Pharma at patients’ expense, Congress should work to lower drug costs, including by expanding price negotiations to allow all patients to access lower negotiated prices, even if they don’t have Medicare.

Read more here: www.citizen.org/news/hundred...

Does it pay? 

According to the CBO, one of the bills – the now-passed ORPHAN Cures Act – returns over $8 billion to pharma’s pockets. The proposed EPIC Act (that Trump essentially endorsed in an April EO) would return tens of billions more.

Thanks to health leaders Emily Bass, Mitchell Warren, Asia Russell, Amanda Banda, and Isata Dumbuya. And to our event co-hosts UNAIDS, Health GAP, People's Medicines Alliance, UAEM, Treatment Action Group, RESULTS, and Partners In Health.

We had a critical discussion about continuing the fight to bring medicines to all, with the first step being bringing that breakthrough — at that price — to the world.

Thanks to UNAIDS' Winnie Byanyima and Unitaid's Tenu Avafia for joining us today and for your leadership.